Kestra Medical Technologies Ltd(KMTS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -2.67 | Insider Own | 59.2% | Shs Outstand | 59.3M | Perf Week | 9.37% |
| Market Cap | 1.78B | Forward P/E | - | EPS next Y | 16.15% | Insider Trans | -1.14% | Shs Float | 24.3M | Perf Month | 4.95% |
| Enterprise Value | 1.66B | PEG | - | EPS next Q | -0.61 | Inst Own | 46.44% | Short Float | 14.11% | Perf Quarter | 29.03% |
| Income | -0.15B | P/S | 16.67 | EPS this Y | -0.79% | Inst Trans | 0.54% | Short Ratio | 9.4 | Perf Half Y | 53.1% |
| Sales | 0.11B | P/B | 7.96 | EPS next 5Y | 11.8% | ROA | -48.85% | Short Interest | 3.43M | Perf YTD | 12.63% |
| Book/sh | 3.75 | P/C | 8.94 | EPS past 3/5Y | -11.52% - | ROE | -73.74% | 52W High | -1.81% ($30.42) | Perf Year | 6.87% |
| Cash/sh | 3.34 | P/FCF | - | Sales past 3/5Y | 131.88% - | ROIC | -50.16% | 52W Low | 72.26% ($17.34) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -5.66% | Gross Margin | 53.89% | Volatility(W/M) | 4.81% 5.97% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 15.52 | Sales Y/Y TTM | 60.72% | Oper. Margin | -134.48% | ATR (14) | 1.57 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.53 | EPS Q/Q | -49.54% | Profit Margin | -140.43% | RSI (14) | 59.83 | Recom | 1.22 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.69 | Sales Q/Q | 59.88% | SMA20 | 7.48% ($27.79) | Beta | 0.49 | Target Price | $30.75 |
| Payout | - | Debt/Eq | 0.34 | Earnings | 2026/9/14 | SMA50 | 12.34% ($26.59) | Rel Volume | 1.48 | Prev Close | $29.99 |
| Employees | 443 | LT Debt/Eq | 0.34 | EPS/Sales Surpr. | -21.77% 6.76% | SMA200 | 25.85% ($23.73) | Avg Volume(3M) | 0.36M | Price | $29.87 |
| IPO | 2025/3/6 | Option/Short | No/Yes | Trades | 5036 | Volume | 538,338 | Change | -0.4% |
🫀 Kestra Medical Technologies (KMTS) is a US-listed medical device company centered on wearable cardiac defibrillators. Through its ASSURE wearable defibrillator and cardiac recovery system platform for patients at high risk of sudden cardiac arrest, it delivers an integrated offering that spans monitoring, therapy, digital health, and patient support. With a rental-based, recurring revenue model, the company is a growth-oriented medical device business rapidly expanding its market share.
Over the past 1 year, on the higher side
2% below its 1-year high.
Traded more than usual. That is 148% of its average volume.
KMTS has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -0.8% this year.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $1,667. Peers typically go for $271.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Long-term returns are roughly flat
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 46.4%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #27 of 51 in the industry
Based on market cap of $2B.
LMAT#24 Lemaitre Vascular Inc $2B PER 29.5 
XRAY#25 DENTSPLY Sirona Inc $2B PER - 
AZTA#26 Azenta Inc $2B PER - KMTS#27 Kestra Medical Technologies Ltd $2B PER - 
STAA#28 Staar Surgical Co $1B PER 370.1 
FAQ
What kind of company is KMTS?
KMTS belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of KMTS?
The market cap of KMTS is approximately $1.8B, ranking 2,159 within its sector.
What is the 52-week high and low for KMTS?
KMTS has recorded a 52-week high of $30.42 and a low of $17.34.
